NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

NCT02872987

RecruitingN/A

Sponsor: Goethe University

Conditions: Acute Lymphoblastic Leukemia, Leukemia, Non-Hodgkin's Lymphoma

Countries: Austria, Germany

The GMALL registry serves the purpose of ALL research and quality assurance. The Registry collects data about diagnostics, treatment and outcome of Adult ALL Patients in the clinical routine, whether or not the patient is treated within a clinical trial.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Acute Lymphoblastic Leukemia (All Subtypes) if treated according to ALL protocols
* Other Types of Leukemia (NK Cell Lymphoma/Leukemia, Biphenotypic Acute Leukemia) if treated according to ALL protocols
* Non-Hodgkin's Lymphoma of Following Subtypes: Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Other NHL) if treated according to B-ALL protocols
* Age minimum 18 yrs

Locations (147)

Graz, Austria
Leoben, Austria
Linz, Austria
Sankt Pölten, Austria
Vienna, Austria
Frankfurt am Main, Hesse, Germany
Aachen, Germany
Altenburg, Germany
Altötting, Germany
Aschaffenburg, Germany
Augsburg, Germany
Bad Saarow, Germany
Bamberg, Germany
Bayreuth, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Berlin, Germany
Bielefeld, Germany
Bielefeld, Germany
Bochum, Germany
Bochum, Germany
Bochum, Germany
Bonn, Germany
Bonn, Germany
Braunschweig, Germany
Bremen, Germany
Bremen, Germany
Chemnitz, Germany
+ 117 more on CT.gov